Total Payments
$4,480
2024 Payments
$1,232
Companies
22
Transactions
299
Medicare Patients
6,094
Medicare Billing
$356,845
Payment Breakdown by Category
Food & Beverage$4,442 (99.1%)
Education$38.91 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,442 | 297 | 99.1% |
| Education | $38.91 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $710.68 | 103 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $598.07 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $555.33 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $535.33 | 36 | $0 (2024) |
| Merck Sharp & Dohme LLC | $467.61 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $287.36 | 20 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $248.40 | 12 | $0 (2023) |
| PREVENTRIC DIAGNOSTICS, INC. | $244.45 | 5 | $0 (2022) |
| ABIOMED | $170.43 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $156.81 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,232 | 74 | Novartis Pharmaceuticals Corporation ($399.73) |
| 2023 | $1,192 | 83 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($227.37) |
| 2022 | $1,206 | 61 | Boehringer Ingelheim Pharmaceuticals, Inc. ($253.53) |
| 2021 | $851.26 | 81 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($252.86) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.15 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.45 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.83 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.95 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: Cardiovascular | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.34 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: Cardiovascular | ||||||
| 09/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.73 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,291 | 1,732 | $266,536 | $74,430 |
| 2022 | 15 | 1,453 | 1,956 | $295,504 | $81,890 |
| 2021 | 16 | 1,841 | 2,291 | $377,426 | $118,480 |
| 2020 | 16 | 1,509 | 1,889 | $290,724 | $82,044 |
Total Patients
6,094
Total Services
7,868
Medicare Billing
$356,845
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 430 | 615 | $129,150 | $42,875 | 33.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 119 | 198 | $30,415 | $9,962 | 32.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 386 | 508 | $53,848 | $4,134 | 7.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 47 | 49 | $9,310 | $3,616 | 38.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 40 | $9,720 | $3,358 | 34.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 42 | $9,072 | $3,186 | 35.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $10,500 | $2,753 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $5,985 | $2,224 | 37.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 63 | 89 | $2,225 | $747.60 | 33.6% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 14 | 14 | $882.00 | $538.58 | 61.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 39 | 47 | $2,820 | $477.90 | 16.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 34 | 37 | $1,480 | $270.24 | 18.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 23 | 24 | $600.00 | $192.96 | 32.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 22 | 23 | $529.00 | $93.52 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 497 | 711 | $149,310 | $53,729 | 36.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 78 | 86 | $24,510 | $7,543 | 30.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 82 | 132 | $20,328 | $6,231 | 30.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 502 | 691 | $73,246 | $5,882 | 8.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $5,589 | $2,060 | 36.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,300 | $1,972 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,160 | $1,443 | 34.7% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2022 | 18 | 22 | $1,386 | $855.04 | 61.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 43 | 52 | $3,120 | $542.76 | 17.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $1,729 | $533.49 | 30.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 38 | 38 | $1,520 | $291.74 | 19.2% |
About Steven Snyder, NP
Steven Snyder, NP is a Nurse Practitioner healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932241155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Steven Snyder, NP has received a total of $4,480 in payments from pharmaceutical and medical device companies, with $1,232 received in 2024. These payments were reported across 299 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,442).
As a Medicare-enrolled provider, Snyder has provided services to 6,094 Medicare beneficiaries, totaling 7,868 services with total Medicare billing of $356,845. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Wilmington, NC
- Active Since 02/13/2007
- Last Updated 08/13/2014
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1932241155
Products in Payments
- LifeVest (Device) $710.68
- JARDIANCE (Drug) $555.33
- VERQUVO (Drug) $467.61
- LEQVIO (Drug) $448.02
- ELIQUIS (Drug) $389.15
- XARELTO (Drug) $287.36
- MULTAQ (Drug) $248.40
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $244.45
- CAMZYOS (Drug) $212.05
- Impella (Device) $170.43
- ENTRESTO (Drug) $150.05
- FARXIGA (Drug) $120.21
- VYNDAQEL (Drug) $38.41
- NEXLETOL (Drug) $38.26
- DEFINITY (Drug) $35.93
- CARDIOMEMS (Device) $33.30
- MITRACLIP (Device) $30.84
- Inpefa (Drug) $30.32
- (5044) MCOT (Device) $30.28
- OPSUMIT (Drug) $29.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Wilmington
Bridgette Williams, Fnp, FNP
Nurse Practitioner — Payments: $32,695
Nurse Practitioner $32,695
Mrs. Colleen Ditro, Apn, APN
Nurse Practitioner — Payments: $16,224
Nurse Practitioner $16,224
Lauren Gardner, Np, NP
Nurse Practitioner — Payments: $13,768
Nurse Practitioner $13,768
Edith Saffo, Np, NP
Nurse Practitioner — Payments: $12,329
Nurse Practitioner $12,329
Rebecca Maphis
Nurse Practitioner — Payments: $12,076
Nurse Practitioner $12,076
Jennifer Hubbard, Aprn, APRN
Nurse Practitioner — Payments: $10,691
Nurse Practitioner $10,691